1,423 results on '"Riekkinen P"'
Search Results
152. Electromyographic and nerve conduction findings in a patient with neuromyotonia, normocalcemic tetany and small-cell lung cancer
153. Long-term efficacy and cognitive effects of vigabatrin
154. Critical evaluation of the postmortem factors influencing neurochemical analyses of brain autopsies
155. PROTEINASE AND PEPTIDASE ACTIVITIES OF HUMAN CEREBROSPINAL FLUID IN MULTIPLE SCLEROSIS
156. Homovanillic acid and 5-hydroxyindoleacetic acid levels in cerebrospinal fluid of patients with senile dementia of Alzheimer type
157. Predictive factors in the functional recovery and outcome of stroke
158. ULTRASTRUCTURAL STUDIES OF MULTIPLE SCLEROSIS BRAIN BIOPSIES
159. Carbamazepine and bone mineral metabolism
160. Substitution of diphenylhydantoin by oxcarbazepine or carbamazepine: double-blind study
161. Discrimination of Alzheimer patients responding to cholinesterase inhibitor therapy
162. Cholinergic and monoaminergic neurons in SDAT and in vascular dementia
163. A NEW NEUTRAL PROTEINASE FROM THE RAT BRAIN
164. BRAIN ACETYLCHOLINESTERASE IN PARKINSON'S DISEASE
165. QUANTITATIVE OCCIPITAL EEG IN ALZHEIMER'S DISEASE
166. Type-2 diabetes and cognitive function in a non-demented population
167. OPTIC NEURITIS-A SIGN OF MULTIPLE SCLEROSIS OR OTHER DISEASES OF THE CENTRAL NERVOUS SYSTEM
168. Diagnostic evaluation of ambulatory, cassette EEG monitoring in 100 epileptic patients
169. Somatostatin-like immunoreactivity in the CSF of patients with dementia associated with alcoholism
170. MORPHOLOGICAL AND BIOCHEMICAL STUDIES ON LIVER BIOPSIES OF PARKINSONIAN PATIENTS TREATED WITH LEVODOPA AND DECARBOXYLASE INHIBITOR
171. European stroke prevention study (ESPS): antithrombotic therapy is also effective in the elderly
172. THE EFFECT OF SMALL DOSE OF ALDOSE REDUCTASE INHIBITOR (SORBINIL) ON DIABETIC NEUROPATHY
173. Short-term withdrawal of antiepileptic medication: effects on attention and memory
174. Therapeutic intervention in mentally retarded adult epileptics
175. FRACTIONATION OF PROTEOLYTIC ENZYMES OF HUMAN CEREBROSPINAL FLUID
176. CEREBROSPINAL FLUID PARAMETERS IN ALZHEIMER'S DISEASE DURING ORG2766 TREATMENT
177. β-ENDORPHIN-LIKE IMMUNOREACTIVITY IN CSF OF PATIENTS WITH ALZHEIMER'S DISEASE
178. Chronic Anticonvulsive Therapy, Peripheral Nerve Conduction Velocity, and EMG
179. Differential involvement of nucleus basalis and medial septum in long-term retention
180. Regulation of EEG delta activity by the cholinergic nucleus basalis
181. Loss of cholinergic neurons in the nucleus basalis induces neocortical electroencephalographic and passive avoidance deficits
182. Gammavinylgaba increases high voltage spindle activity in control and nucleus basalis-lesioned rats after sub-chronic treatment
183. Tetrahydroaminoacridine improves passive avoidance retention defects induced by aging and medial septal lesion but not by fimbria-fornix lesion
184. Comparison of the effects of acute and chronic ibotenic and quisqualic acid nucleus basalis lesioning
185. Combination of atipamezole and tetrahydroaminoacridine/pilocarpine treatment suppresses high voltage spindle activity in aged rats
186. The effects of THA on scopolamine and nucleus basalis lesion-induced EEG slowing
187. The cholinergic system and EEG slow waves
188. Effect of alpha2 antagonists and an agonist on EEG slowing induced by scopolamine and lesion of the nucleus basalis
189. SPECT and MRI analysis in Alzheimer's disease: relation to apolipoprotein E epsilon 4 allele.
190. α2C-Adrenoceptors modulate the effect of methylphenidate on response rate and discrimination accuracy in an operant test
191. Apolipoprotein E-deficient mice are not more susceptible to the biochemical and memory deficits induced by nucleus basalis lesion
192. Overexpression of Alpha2C-adrenoceptors impairs water maze navigation
193. Impaired recovery of noradrenaline levels in apolipoprotein E-deficient mice after N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine lesion
194. Vigabatrin, a gabaergic antiepileptic drug, causes concentric visual field defects
195. Antiplatelet treatment does not reduce the severity of subsequent stroke
196. The α2 agonist, clonidine, improves spatial working memory performance in Parkinson's disease
197. Clonidine impairs sustained attention and memory in Alzheimer's disease
198. Hippocampal damage and the onset of epilepsy
199. Role of α2C-adrenoceptor subtype in spatial working memory as revealed by mice with targeted disruption of the α2C-adrenoceptor gene
200. Systemic Administration of Atipamezole, a Selective Antagonist of Alpha-2 Adrenoceptors, Facilitates Behavioural Activity but does not Influence Short-term or Long-term Memory in Trimethyltin-intoxicated and Control Rats
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.